Holen Sie sich die Stockscreener-App
50.11
0.32%
0.16
Supernus Pharmaceuticals Inc Aktie (SUPN) Neueste Nachrichten
MACD Signal: Is Supernus Pharmaceuticals Inc part of any major index2026 Year in Review & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Tudor Investment Corp ET AL Invests $1.43 Million in Supernus Pharmaceuticals - National Today
Responsive Playbooks and the SUPN Inflection - Stock Traders Daily
Q4 2025 Supernus Pharmaceuticals Inc Earnings Call Transcript - GuruFocus
Supernus Pharmaceuticals, Inc. (SUPN) Stock forecasts - Yahoo Finance UK
Supernus Pharmaceuticals (SUPN) Enters $350M Asset Purchase Agre - GuruFocus
Supernus Pharmaceuticals Acquires NV-5138 (SPN-820) Compound from Navitor Pharmaceuticals in Asset Purchase Agreement - Minichart
Supernus enters into asset purchase agreement with Navitor - TipRanks
Supernus (SUPN) Acquires Key Assets from Navitor Pharmaceuticals - GuruFocus
Supernus Acquires NV-5138 Asset in New Agreement - TipRanks
Supernus Pharmaceuticals Inc Enters Asset Purchase Agreement With Navitor On April 1, 2026 - TradingView — Track All Markets
According to a document submitted to the U.S. Securities and Exchange Commission (SEC), Supernus Pharmaceuticals has reached an agreement to acquire the asset portfolio related to the candidate drug NV-5138 (also known as SPN-820). - Bitget
[8-K] SUPERNUS PHARMACEUTICALS, INC. Reports Material Event - Stock Titan
RSI Check: Is Supernus Pharmaceuticals Inc a stock for growth or value investorsWeekly Stock Recap & Comprehensive Market Scan Reports - baoquankhu1.vn
Supernus Pharmaceuticals, Inc. (SUPN) Hits Fresh High: Is There Still Room to Run? - MSN
Supernus Pharmaceuticals Inc (S49.DU) stock price, news, quote and history - Yahoo Finance UK
Understanding the Setup: (SUPN) and Scalable Risk - Stock Traders Daily
Supernus Pharma Insider Sells $5.4 Million as Stock Surges 53% in a Year - aol.com
Hennion & Walsh Asset Management Inc. Has $4.01 Million Position in Supernus Pharmaceuticals, Inc. $SUPN - MarketBeat
Tudor Investment Corp ET AL Makes New Investment in Supernus Pharmaceuticals, Inc. $SUPN - MarketBeat
Supernus Pharmaceuticals, Inc. $SUPN Stock Holdings Lowered by JPMorgan Chase & Co. - MarketBeat
Market Trends: Is now the right time to enter Supernus Pharmaceuticals IncWall Street Watch & High Yield Equity Trading Tips - baoquankhu1.vn
Vanguard disaggregates holdings after internal realignment (SUPN) - Stock Titan
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Given Consensus Rating of "Hold" by Analysts - MarketBeat
D&O policy doesn’t cover antitrust suit over drug acquisition: Court - businessinsurance.com
Supernus Pharmaceuticals (NASDAQ:SUPN) Shares Pass Above 200-Day Moving AverageWhat's Next? - MarketBeat
Insurer Need Not Cover Parkinson's Drug Antitrust Dispute - Law360
Jefferies reiterates Supernus Pharmaceuticals stock Buy rating By Investing.com - Investing.com India
Jefferies reiterates Supernus Pharmaceuticals stock Buy rating - Investing.com UK
Breakout Watch: What is the target price for Supernus Pharmaceuticals Inc stockQuarterly Growth Report & Low Volatility Stock Suggestions - baoquankhu1.vn
SUPN Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
The Technical Signals Behind (SUPN) That Institutions Follow - Stock Traders Daily
SUPN Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
SUPN Technical Analysis & Stock Price Forecast - Intellectia AI
Quarterly Risk: Does Supernus Pharmaceuticals Inc have strong EBITDA margins2026 Technicals & High Accuracy Buy Signal Tips - baoquankhu1.vn
Insider Selling: Supernus Pharmaceuticals (NASDAQ:SUPN) VP Sells 7,250 Shares of Stock - MarketBeat
Supernus Pharmaceuticals (NASDAQ:SUPN) VP Sells $2,514,000.00 in Stock - MarketBeat
[Form 4] SUPERNUS PHARMACEUTICALS, INC. Insider Trading Activity - Stock Titan
Supernus Pharmaceuticals Q4 2025 earnings preview - MSN
SUPN (NASDAQ: SUPN) Form 144 lists 57,250-share resale after option exercise - Stock Titan
SUPN Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Supernus Pharmaceuticals CEO Sells $1.76M in Stock - National Today
Insider Sell Alert: Frederick Hudson Sells Shares of Supernus Ph - GuruFocus
[144] SUPERNUS PHARMACEUTICALS, INC. SEC Filing - Stock Titan
Supernus (NASDAQ: SUPN) CEO-linked KBT Trust sells 35,000 shares under 10b5-1 plan - Stock Titan
Director at Supernus (NASDAQ: SUPN) sells 5,369 shares - Stock Titan
SUPN SEC FilingsSupernus Pharma 10-K, 10-Q, 8-K Forms - Stock Titan
Assessing Supernus Pharmaceuticals (SUPN) Valuation After Recent Mixed Short And Long Term Returns - simplywall.st
Aristotle Capital Boston LLC Sells 503,122 Shares of Supernus Pharmaceuticals, Inc. $SUPN - MarketBeat
1.06%
1.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):